Hirofumi Nishida

New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: mitochondrial ion channels and cardioprotection.

T. Ogura, H. Nakaya, Toshiaki Sato, 2009, Journal of pharmacological sciences.

Effects of sulfonylureas on mitochondrial ATP‐sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy

M. Miyazaki, H. Nakaya, Toshiaki Sato, 2006, Diabetes/metabolism research and reviews.

A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia.

C. Yabe-Nishimura, Kazumi Iwata, Akio Matsumoto, 2015, Journal of pharmacological sciences.

Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels.

M. Miyazaki, H. Nakaya, Toshiaki Sato, 2007, Cardiovascular research.

Termination of aconitine-induced atrial fibrillation by the KACh-channel blocker tertiapin: underlying electrophysiological mechanism.

Akio Matsumoto, H. Nakaya, Hirofumi Nishida, 2014, Journal of pharmacological sciences.

Biochemistry and physiology of mitochondrial ion channels involved in cardioprotection

Akio Matsumoto, H. Nakaya, Hirofumi Nishida, 2010, FEBS letters.

Cilostazol, a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca 2+ -Activated K + Channels in Rabbit Hearts

H. Nakaya, Toshiaki Sato, Hirofumi Nishida, 2008 .

Late-term regression of stenosis at the kink site in the internal thoracic artery in two cases.

M. Miyazaki, M. Imamaki, A. Ishida, 2006, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Glimepiride treatment upon reperfusion limits infarct size via the phosphatidylinositol 3-kinase/Akt pathway in rabbit hearts.

M. Miyazaki, H. Nakaya, Toshiaki Sato, 2009, Journal of pharmacological sciences.

Physicochemical, Morphological and Therapeutic Evaluation of Agarose Hydrogel Particles as a Reservoir for Basic Fibroblast Growth Factor

M. Miyazaki, K. Moribe, Keiji. Yamamoto, 2008, Pharmaceutical development and technology.

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (Cilostazol), a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca2+-Activated K+ Channels in Rabbit Hearts

M. Miyazaki, H. Nakaya, Toshiaki Sato, 2008, Journal of Pharmacology and Experimental Therapeutics.

A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia.

C. Yabe-Nishimura, Akio Matsumoto, H. Nakaya, 2015, Journal of pharmacological sciences.